Inner Mongolia Furui Medical Hits Day Low Amid Price Pressure at CNY 52.12

Inner Mongolia Furui Medical Science Co., Ltd. experienced a notable decline today, with the stock dropping by 3.28% on March 13, 2026. The stock reached an intraday low of CNY 52.12, reflecting a challenging trading session. Over the past week, the stock has seen a decrease of 6.86%, and its performance over the last month has been even more pronounced, with a decline of 20.08%. Despite a strong annual performance of 53.19%, the company has faced significant headwinds, including a 23.1% drop in profits over the past year. The stock's market capitalization stands at CNY 15,142 million, categorizing it as a large-cap entity within the Pharmaceuticals & Biotechnology industry. Key financial metrics indicate a price-to-earnings ratio of 124.00 and a return on equity of 10.38%. However, the company's valuation appears elevated, with a price-to-book ratio of 7.95. As Inner Mongolia Furui Medical Science navigates these market dynamics, its recent performance underscores the complexities within the current financial landscape.